Evidence map›Paper›PMID 35239914›Full record

Observational studyRevista da Sociedade Brasileira de Medicina Tropical2022

Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience.

Alejandro Marcel Hasslocher-Moreno, Roberto Magalhães Saraiva, Gilberto Marcelo Sperandio da Silva, Sergio Salles Xavier, Andréa Silvestre de Sousa, Andrea Rodrigues da Costa, Fernanda de Souza Nogueira Sardinha Mendes, Mauro Felippe Felix Mediano

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Revista da Sociedade Brasileira de Medicina Tropical, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alejandro Marcel Hasslocher-MorenoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-5430-7222
Roberto Magalhães SaraivaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-2263-4261
Gilberto Marcelo Sperandio da SilvaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-0468-4417
Sergio Salles XavierFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-9337-0363
Andréa Silvestre de SousaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0001-8266-4801
Andrea Rodrigues da CostaFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0002-5033-4856
Fernanda de Souza Nogueira Sardinha MendesFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0003-2033-1715
Mauro Felippe Felix MedianoFundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil.ORCID http://orcid.org/0000-0001-6369-3631
Instituto Evandro Chagas · BRUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated the mortality rates of patients with Chagas disease (CD) during the coronavirus disease 2019 (COVID-19) pandemic and assessed the association between this mortality and CD clinical presentation and comorbidities.

methodsThis was an observational retrospective study with clinical data retrieved from medical records.

resultsComorbidities were more prevalent among patients who died from COVID-19 than those who died from other causes. The proportion of patients according to CD clinical presentation was similar between the two groups.

conclusionsThe prevalence of comorbidities seems to be related to a poorer prognosis in CD and COVID-19.

Indexed as

Chagas DiseaseCOVID-19HumansPandemicsReferral and ConsultationRetrospective StudiesSARS-CoV-2

Identifiers

PMID35239914
PMCPMC8909444
OpenAlexW4214621530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.